HomeNewsBusinessRLDA invites bids to lease two plots for commercial development at Katra

RLDA invites bids to lease two plots for commercial development at Katra

While e-bids are invited, the last date for submission is likely to be extended in view of the coronavirus lockdown.

March 25, 2020 / 20:08 IST
Story continues below Advertisement

This Chaitra Navratri, the Railway Land Development Authority (RLDA) has invited bids for leasing two plots for commercial development located near the Shri Mata Vaishno Devi Katra railway station at Katra, Jammu and Kashmir, at a reserve price of Rs 29.15 crore.

The last date for submission of the e-bid is April 9 but it is likely to be extended in view of the lockdown across the country following the coronavirus pandemic, RLDA officials said.

Story continues below Advertisement

The two plots are spread across 15,352 sq metre. The plot is proposed to be leased out in two parts with a reserve price of Rs 14.18 crore and Rs 14.97 crore, they said.

“This plot is proposed to be leased in two parts. The permissible FSI is 2.50. Any developer can take one or both plots. These plots can be developed as destination wedding farmhouses or 3-5 star hotels at this picturesque location which is surrounded by greenery all round ” said Ved Prakash Dudeja, vice chairman, RLDA.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show